Chronic migraine long-term regular treatment with onabotulinumtoxinA: a retrospective real-life observational study up to 4 years of therapy

ConclusionsThis study appears to reconfirm the benefits of long-lasting CM prevention with BoNT-A, thus supporting quarterly treatment with BoNT-A over several year.

http://link.springer.com/10.1007/s10072-020-04283-y

Source: Neurological Sciences - February 11, 2020 Category: Neurology Source Type: research